您当前的位置:
首页 >
文章列表页 >
Analysis on Composition Principles of Prescriptions for Viral Pneumonia Using Traditional Chinese Medicine Inheritance System
更新时间:2024-01-04
    • Analysis on Composition Principles of Prescriptions for Viral Pneumonia Using Traditional Chinese Medicine Inheritance System

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 21, Issue 13, Pages: 208-211(2015)
    • DOI:10.13422/j.cnki.syfjx.2015130208    

      CLC: R259
    • Published:2015

    移动端阅览

  • LU Li-wei, ZHANG Gui-ju, JI Xu-ming, et al. Analysis on Composition Principles of Prescriptions for Viral Pneumonia Using Traditional Chinese Medicine Inheritance System[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(13): 208-211. DOI: 10.13422/j.cnki.syfjx.2015130208.

  •  
  •  

0

Views

4

下载量

7

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Thoughts of Syndrome Differentiation and Treatment and Effect Mechanism of Haoqin Qingdantang in Treating Viral Pneumonia Based on Theory of Treating Different Diseases with Same Therapy
Immunity-inflammation Mechanism of Viral Pneumonia and Traditional Chinese Medicine Treatment Based on Theory of Healthy Qi and Pathogenic Qi
Discussion on Traditional Chinese Medicine Theory and Pharmacological Mechanism of Xuanfei Baidu Prescription in Treatment of Viral Pneumonia
Therapeutic Effect of Gegentang Granules on Mouse Model with hCoV-229E Pneumonia and Hanshi Yidu Xifei Syndrome
Effect of Chuankezhi Injection on Prevention and Treatment of H1N1 Influenza Virus in Mice

Related Author

PENG Xin
XU Haotian
LIANG Lei
LUAN Zheyu
WANG Hanxiao
ZHANG Yihao
YANG Kun
FENG Jihong

Related Institution

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin University of Traditional Chinese Medicine
The Second Affiliated Hospital of Tianjin University of TCM
Tianjin University of Traditional Chinese Medicine(TCM)
Reyoung Pharmaceutical Co. Ltd.
0